To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The development process for the ...
For more than two years, the U.S. Federal Trade Commission (FTC) has been taking certain drugmakers to task over their alleged listing of "improper" patents in an FDA registry, a practice the agency ...
(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) announced that the U.S. FDA has approved its Epinephrine injection USP, 1 mg/mL, in both single-dose and multi-dose for use in U.S. hospitals.
Amneal said that the Food and Drug Administration has approved its epinephrine injection in both single and multi-dose vials for hospitals. The Bridgewater, NJ-based biopharmaceutical company said ...
JERUSALEM, Nov 19 (Reuters) - Teva Pharmaceutical Industries (TEVA.TA), opens new tab said on Wednesday it was calling on startups to join its new platform to develop technologies to deal with a host ...
A new mold concept developed by Zahoransky is engineered to accelerate the mass production of housings for insulin pens and auto injectors in a space- and energy-efficient manner. The Z.Sonic turn ...
I love a peanut butter and tuna sandwich. But when I was a kid, my school outlawed peanuts. My classmate was super allergic to them. So, we had a rule to keep our friend safe. I packed plain tuna fish ...
The FDA recently approved the first needle-free epinephrine product (neffy), an alternative to injectable epinephrine (EpiPen) for anaphylaxis and other allergic reactions -- and I will be prescribing ...
If you or someone you love has an allergy that results in anaphylaxis, you know how important it is to administer epinephrine at the first sign of a reaction. Epinephrine is the frontline treatment ...
As part of the back-to-school rush, GoodRx, a platform for medication savings, reports the demand for epinephrine (EpiPen, EpiPen Jr, Adrenaclick, Auvi-Q) auto-injectors tends to spike in the summer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results